Publication date: December 2026 Source: The Breast, Volume 90 Author(s): Han Yi Lee, Whee Sze Ong, Vivianne Tjan-Heijnen, Matteo Lambertini, Yen Shen Lu, Kyong Hwa Park, Yasuaki Sagara, Maria Vidal, Ander Urruticoechea, Mafalda Oliveira, Eva Ciruelos, Nicholas Zdenkowski, Philippe L. Bedard, Michail Ignatiadis, Soo Chin Lee, Joohyuk Sohn, Khalil Zaman, Gustavo Werutsky, Giuseppe Curigliano, Seamus O'Reilly
To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission. // The Breast. – URL: https://www.sciencedirect.com/science/article/pii/S0960977626002456?dgcid=rss_sd_all
To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission. The Breast. https://www.sciencedirect.com/science/article/pii/S0960977626002456?dgcid=rss_sd_all
“To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission.” The Breast.
@article{article67551,
title = {To stop or not to stop? International physician survey on HER2 targeted therapy for metastatic breast cancer patients in remission},
journal = {The Breast},
url = {https://www.sciencedirect.com/science/article/pii/S0960977626002456?dgcid=rss_sd_all}
}